Production (Stage)
Genocea Biosciences, Inc.
GNCAQ
$0.00
$0.000.00%
OTC PK
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -15.98M | -13.28M | -3.62M | -4.31M | -11.98M |
| Total Depreciation and Amortization | 400.00K | -292.00K | 397.00K | 371.00K | 381.00K |
| Total Amortization of Deferred Charges | -- | 700.00K | -- | -- | -- |
| Total Other Non-Cash Items | 985.00K | 754.00K | -7.22M | -9.38M | -56.00K |
| Change in Net Operating Assets | -616.00K | 1.01M | -916.00K | 2.80M | -735.00K |
| Cash from Operations | -15.21M | -11.11M | -11.36M | -10.51M | -12.39M |
| Capital Expenditure | -961.00K | -935.00K | -530.00K | -714.00K | -1.11M |
| Sale of Property, Plant, and Equipment | 22.00K | 15.00K | 0.00 | 0.00 | 65.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -939.00K | -920.00K | -530.00K | -714.00K | -1.04M |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 10.00M |
| Total Debt Repaid | -1.25M | -1.25M | 0.00 | 0.00 | -13.98M |
| Issuance of Common Stock | 387.00K | 1.52M | 399.00K | 5.59M | 4.06M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | -377.00K |
| Cash from Financing | -863.00K | 265.00K | 399.00K | 5.59M | -297.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.01M | -11.76M | -11.49M | -5.64M | -13.73M |